Topotecan in Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

Author： Bookman M.A. Blessing J.A. Hanjani P. Herzog T.J. Andersen W.A.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.77, Iss.3, 2000-06, pp. : 446-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Muderspach L.I. Blessing J.A. Levenback C. Moore J.L.

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 213-215

Elsevier

Access to resources Recommend Favorite

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study

By Fracasso P.M. Blessing J.A. Wolf J. Rocereto T.F. Berek J.S. Waggoner S.

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite

Phase II Evaluation of Altretamine for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Rose P.G. Blessing J.A. Arseneau J.

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 100-102

Academic Press

Access to resources Recommend Favorite

Evaluation of Gemcitabine in Patients with Squamous Cell Carcinoma of the Cervix: A Phase II Study of the Gynecologic Oncology Group

By Schilder R.J. Blessing J.A. Morgan M. Mangan C.E. Rader J.S.

Gynecologic Oncology, Vol. 76, Iss. 2, 2000-02 ,pp. : 204-207

Elsevier

Access to resources Recommend Favorite

Cisplatin and Pentoxifylline in Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group

By Mannel R.S. Blessing J.A. Boike G.

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 64-66

Elsevier

Access to resources Recommend Favorite